Our diversity of skills and the collective experience of the team at Glycotope are what make us strong
The contribution of each individual employee is valued to constantly develop and improve our approach. We believe in supportive cooperation at every level of our company, as well as with our partners, to achieve our common goals.
Henner serves as Managing Director of Glycotope since 2014. He has more than 20 years of experience in management functions including strategy, finance, operations and venture capital.
Head of Research & Development
Antje heads the Research & Development department. She is a biochemist specialized in the development of recombinant antibody-based therapeutics.
Head of BD & Program Management
Patrik heads the business development and program management. He is an immunologist specialized in the development of therapeutics in the field of oncology.
Director Preclinical Pharmacology
Anika leads the Preclinical Pharmacology group. She is an immunologist specialized in the pharmacological in vitro and in vivo assessment of antibody-based therapeutics.
Director Platform Development
Sophie leads the Platform Development group. She is a biotechnologist specialized in bioanalytics.
Head of Finance & Controlling
Jenny serves as Head of Finance and Controlling since 2017. She has more than 12 years of experience in finance and controlling functions.
Sebastian serves as Legal Counsel at Glycotope. He is a business lawyer specialized in the fields of contract and company law.